Launch of Phase 2 of the application evaluation in Amman, Jordan
Share
Share on Facebook
Share on Telegram
Share on LinkedIn
Share on Twitter
Copy link
Page url is copied
Phase 2 of the evaluation of the application began in February in Amman. This essential step consists in testing the performance and the functioning of the expert system in order to calibrate the image processing by the artificial intelligence present in the application.
The rapid diagnostic test (RDT) for measles produced by DIATROPIX, the manufacturing platform of the Pasteur Institute in Dakar, has reached a new milestone.The MSF Foundation has been su...
The Optimilk F-60 project has reached a key milestone: the first children have been enrolled in the Phase 1 clinical trial evaluating the safety and tolerability of F-60, a new therapeuti...
